Aarti Drugs Limited · NSE: AARTIDRUGS · BSE: 524348
Aarti Drugs
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 31 Jul 2026.
Q1 FY27 · Consolidated
Revenue
702.78₹ Cr
+19.0% vs year ago
Net profit
50.13₹ Cr
−7.1% vs year ago
EPS, basic
5.49₹
−7.1% vs year ago
Net margin
7.1%
−2.0 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 702.78 | +19.0% | 50.13 | −7.1% | 5.49 | 31 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 720.30 | +6.4% | 55.26 | −12.0% | 6.05 | 15 May 2026 |
| Q3 FY26Oct–Dec 2025 | 601.71 | +8.1% | 40.55 | +9.3% | 4.44 | 03 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 652.79 | +9.1% | 45.16 | +29.2% | 4.95 | 07 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 590.51 | +6.3% | 53.97 | +62.2% | 5.91 | 18 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 676.76 | +9.2% | 62.77 | +32.7% | 6.88 | 06 May 2025 |
| Q3 FY25Oct–Dec 2024 | 556.60 | −8.1% | 37.09 | +1.0% | 4.06 | 30 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 598.33 | −6.7% | 34.96 | −11.7% | 3.83 | 25 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 555.34 | −16.0% | 33.27 | −30.6% | 3.62 | 29 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 619.99 | −16.5% | 47.31 | −15.8% | 5.15 | 06 May 2024 |
| Q3 FY24Oct–Dec 2023 | 605.94 | −8.7% | 36.71 | +0.1% | 3.99 | 25 Jan 2024 |
| Q2 FY24Jul–Sep 2023 | 641.54 | −6.7% | 39.60 | +2.2% | 4.29 | 21 Oct 2023 |
| Q1 FY24Apr–Jun 2023 | 661.11 | +6.3% | 47.97 | +37.9% | 5.18 | 22 Jul 2023 |
| Q4 FY23Jan–Mar 2023 | 742.41 | +6.9% | 56.18 | +1.6% | 6.07 | 02 May 2023 |
| Q3 FY23Oct–Dec 2022 | 663.96 | +4.6% | 36.67 | −37.1% | 3.96 | 28 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 687.72 | +18.7% | 38.74 | −9.0% | 4.18 | 22 Oct 2022 |
| Q1 FY23Apr–Jun 2022 | 621.96 | +7.2% | 34.78 | −28.7% | 3.76 | 28 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 694.27 | +38.4% | 55.32 | +7.1% | 5.97 | 10 May 2022 |
| Q3 FY22Oct–Dec 2021 | 634.80 | +19.7% | 58.28 | −14.3% | 6.29 | 01 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 579.62 | +0.3% | 42.58 | −43.4% | 4.60 | 28 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 579.95 | +6.5% | 48.81 | −42.9% | 5.25 | 28 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 501.75 | +11.6% | 51.65 | −12.2% | 5.54 | 17 May 2021 |
| Q3 FY21Oct–Dec 2020 | 530.25 | +12.0% | 68.03 | +144.9% | 7.30 | 27 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 578.11 | +21.1% | 75.27 | +133.0% | 32.30 | 24 Oct 2020 |
| Q1 FY21Apr–Jun 2020 | 544.67 | +34.3% | 85.45 | +280.6% | 36.67 | 27 Jul 2020 |
| Q4 FY20Jan–Mar 2020 | 449.64 | −2.1% | 58.86 | +114.5% | 25.26 | 18 May 2020 |
| Q3 FY20Oct–Dec 2019 | 473.51 | +24.6% | 27.78 | +33.0% | 11.92 | 07 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 477.50 | +37.4% | 32.31 | +79.0% | 13.87 | 29 Oct 2019 |
| Q1 FY20Apr–Jun 2019 | 405.43 | +8.3% | 22.45 | −3.9% | 9.56 | 27 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 459.14 | — | 27.44 | — | 12.06 | 16 May 2019 |
| Q3 FY19Oct–Dec 2018 | 380.10 | — | 20.89 | — | 8.86 | 12 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 347.41 | — | 18.05 | — | 7.65 | 06 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 374.29 | — | 23.37 | — | 9.82 | 17 Aug 2018 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 627.45 | +20.4% | 50.85 | +4.5% | 5.57 | 31 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 631.68 | +1.4% | 44.96 | −26.9% | 4.93 | 15 May 2026 |
| Q3 FY26Oct–Dec 2025 | 528.80 | +2.8% | 33.84 | −12.2% | 3.71 | 03 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 578.95 | +6.6% | 41.78 | +37.5% | 4.58 | 07 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 520.96 | +5.7% | 48.64 | +80.8% | 5.33 | 18 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 622.96 | +11.3% | 61.48 | +70.1% | 6.74 | 06 May 2025 |
| Q3 FY25Oct–Dec 2024 | 514.54 | −4.4% | 38.53 | +21.9% | 4.22 | 30 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 543.09 | −6.0% | 30.39 | −12.1% | 3.33 | 25 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 492.96 | −16.7% | 26.91 | −31.9% | 2.93 | 29 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 559.53 | −19.7% | 36.14 | −32.0% | 3.93 | 06 May 2024 |
| Q3 FY24Oct–Dec 2023 | 538.21 | −14.0% | 31.62 | −13.9% | 3.44 | 25 Jan 2024 |
| Q2 FY24Jul–Sep 2023 | 577.54 | −7.6% | 34.58 | −5.5% | 3.75 | 21 Oct 2023 |
| Q1 FY24Apr–Jun 2023 | 591.63 | +7.3% | 39.54 | +50.1% | 4.27 | 22 Jul 2023 |
| Q4 FY23Jan–Mar 2023 | 696.41 | +8.6% | 53.17 | +0.3% | 5.74 | 02 May 2023 |
| Q3 FY23Oct–Dec 2022 | 625.53 | +5.4% | 36.71 | −34.3% | 3.96 | 28 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 624.83 | +22.3% | 36.58 | −9.9% | 3.95 | 22 Oct 2022 |
| Q1 FY23Apr–Jun 2022 | 551.20 | +9.0% | 26.35 | −42.1% | 2.85 | 28 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 641.48 | +41.9% | 53.00 | +5.5% | 5.72 | 10 May 2022 |
| Q3 FY22Oct–Dec 2021 | 593.21 | +25.7% | 55.85 | −13.6% | 6.03 | 01 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 510.70 | −0.9% | 40.61 | −41.8% | 4.39 | 28 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 505.79 | +6.4% | 45.54 | −37.6% | 4.90 | 28 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 452.08 | +11.2% | 50.24 | −11.2% | 5.39 | 17 May 2021 |
| Q3 FY21Oct–Dec 2020 | 472.10 | +13.6% | 64.66 | +141.7% | 6.94 | 27 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 515.16 | +16.4% | 69.78 | +126.6% | 29.95 | 24 Oct 2020 |
| Q1 FY21Apr–Jun 2020 | 475.55 | +28.5% | 73.03 | +238.6% | 31.34 | 27 Jul 2020 |
| Q4 FY20Jan–Mar 2020 | 406.57 | −6.0% | 56.56 | +120.2% | 24.28 | 18 May 2020 |
| Q3 FY20Oct–Dec 2019 | 415.61 | +18.5% | 26.75 | +26.5% | 11.48 | 07 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 442.71 | +38.6% | 30.80 | +70.8% | 13.22 | 29 Oct 2019 |
| Q1 FY20Apr–Jun 2019 | 370.02 | +5.3% | 21.57 | −3.7% | 9.19 | 27 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 432.54 | — | 25.69 | — | 11.31 | 16 May 2019 |
| Q3 FY19Oct–Dec 2018 | 350.65 | — | 21.15 | — | 8.97 | 12 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 319.51 | — | 18.03 | — | 7.65 | 06 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 351.55 | — | 22.39 | — | 9.40 | 17 Aug 2018 |
66 filings on record for this company.